Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03060759 · ClinicalTrials.gov registry record · NA
Light Therapy as Treatment for Fatigue in Multiple Sclerosis
A NA study of Multiple Sclerosis (Relapsing Remitting), sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT03060759 is a NA study of Multiple Sclerosis (Relapsing Remitting) that has completed, run by Massachusetts General Hospital. The registered enrollment target is 35 participants, below the 561-participant average among 29 other Multiple Sclerosis (Relapsing Remitting) trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03060759, a NA study of Multiple Sclerosis (Relapsing Remitting), has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective study will randomize 1:1 people living with multiple sclerosis-associated fatigue to one of two spectra of light therapy. Each participant will be asked to use the light box twice daily at home or at the workplace at preset hours during the day for a total of four weeks. Participants will be asked to record their fatigue on standard measurement scales before, during, and after the use of the light therapy box. The investigators anticipate a reduction in self-reported fatigue following the use of the light box therapy of a particular spectrum of light among people living with multiple sclerosis.
Conditions Studied
Interventions
- DEVICE Light Therapy box
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2019-11-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03060759
The ClinicalTrials.gov registry entry for NCT03060759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 561-participant average among 29 other Multiple Sclerosis (Relapsing Remitting) trials with a reported enrollment target (94% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Sclerosis (Relapsing Remitting) appearing as the primary indexed condition, and to 1 intervention - of which Light Therapy box is the first listed.
NCT03060759 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03060759 about?
NCT03060759 is a clinical study titled "Light Therapy as Treatment for Fatigue in Multiple Sclerosis". This prospective study will randomize 1:1 people living with multiple sclerosis-associated fatigue to one of two spectra of light therapy. Each participant will be asked to use the light box twice daily at home or at the workplace at preset hours during the day for a total of four weeks. Participant...
What is the current status of trial NCT03060759?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2017-04-01. Estimated completion is 2019-11-04.
What conditions does trial NCT03060759 study?
This clinical trial studies the following conditions: Multiple Sclerosis (Relapsing Remitting).
What interventions are being tested in trial NCT03060759?
The interventions under investigation include: Light Therapy box (DEVICE).
Who is sponsoring clinical trial NCT03060759?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03060759 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis (Relapsing Remitting)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
RECRUITING · NA
-
Intermittent Hypoxia in Persons With Multiple Sclerosis
RECRUITING · NA
-
Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
RECRUITING · NA
-
Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
RECRUITING · NA
-
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
RECRUITING · NA
-
The Synergistic Effects of AIH and FES in Persons With MS
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.